- Home
- ANVS vs ALTS Comparison
ANVS vs ALTS Comparison
Compare ANVS & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- ALTS
- Stock Information
- Founded
- ANVS 2008
- ALTS 1976
- Country
- ANVS United States
- ALTS United States
- Employees
- ANVS N/A
- ALTS N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- ANVS Health Care
- ALTS
- Exchange
- ANVS Nasdaq
- ALTS NYSE
- Market Cap
- ANVS 44.6M
- ALTS 125.5M
- IPO Year
- ANVS 2020
- ALTS N/A
- Fundamental
- Price
- ANVS $2.69
- ALTS $7.45
- Analyst Decision
- ANVS Strong Buy
- ALTS
- Analyst Count
- ANVS 4
- ALTS 0
- Target Price
- ANVS $18.00
- ALTS N/A
- AVG Volume (30 Days)
- ANVS 438.8K
- ALTS 304.5K
- Earning Date
- ANVS 08-14-2025
- ALTS 08-18-2025
- Dividend Yield
- ANVS N/A
- ALTS N/A
- EPS Growth
- ANVS N/A
- ALTS N/A
- EPS
- ANVS N/A
- ALTS N/A
- Revenue
- ANVS N/A
- ALTS $18,046,000.00
- Revenue This Year
- ANVS N/A
- ALTS $185.91
- Revenue Next Year
- ANVS N/A
- ALTS $64.93
- P/E Ratio
- ANVS N/A
- ALTS N/A
- Revenue Growth
- ANVS N/A
- ALTS N/A
- 52 Week Low
- ANVS $1.11
- ALTS $1.29
- 52 Week High
- ANVS $12.58
- ALTS $10.95
- Technical
- Relative Strength Index (RSI)
- ANVS 56.73
- ALTS 49.44
- Support Level
- ANVS $2.63
- ALTS $6.60
- Resistance Level
- ANVS $2.89
- ALTS $8.12
- Average True Range (ATR)
- ANVS 0.22
- ALTS 0.79
- MACD
- ANVS 0.02
- ALTS -0.03
- Stochastic Oscillator
- ANVS 82.42
- ALTS 68.18
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.